Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459407 · ClinicalTrials.gov registry record · Phase 1
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
A Phase 1 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT00459407 is a Phase 1 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 50 participants.
The verdict
NCT00459407, a Phase 1 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
Green tea extract contains ingredients that may prevent or slow the growth of prostate cancer. This phase I trial is studying how well green tea extract works in treating patients with prostate cancer undergoing surgery to remove the prostate
Interventions
- DRUG placebo
- OTHER laboratory biomarker analysis
- OTHER immunohistochemistry staining method
- OTHER immunoenzyme technique
- DIETARY_SUPPLEMENT defined green tea catechin extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-03 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00459407
The ClinicalTrials.gov registry entry for NCT00459407 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which placebo is the first listed.
NCT00459407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00459407 about?
NCT00459407 is a clinical study titled "Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate". Green tea extract contains ingredients that may prevent or slow the growth of prostate cancer. This phase I trial is studying how well green tea extract works in treating patients with prostate cancer undergoing surgery to remove the prostate
What is the current status of trial NCT00459407?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2007-03. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00459407?
The interventions under investigation include: placebo (DRUG), laboratory biomarker analysis (OTHER), immunohistochemistry staining method (OTHER), immunoenzyme technique (OTHER), defined green tea catechin extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00459407?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.